United States (US) Biosimilars Market (2024-2030) Outlook | Revenue, Industry, Value, Trends, Growth, Companies, Share, Analysis, Size, Forecast

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC069920 Publication Date: Jun 2021 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Key Highlights of the Report:

  • United States (US) Biosimilars Market Outlook
  • Market Size of United States (US) Biosimilars Market, 2020
  • Forecast of United States (US) Biosimilars Market, 2030
  • Historical Data and Forecast of United States (US) Biosimilars Revenues & Volume for the Period 2020 - 2030
  • United States (US) Biosimilars Market Trend Evolution
  • United States (US) Biosimilars Market Drivers and Challenges
  • United States (US) Biosimilars Price Trends
  • United States (US) Biosimilars Porter's Five Forces
  • United States (US) Biosimilars Industry Life Cycle
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Product for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Insulin for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Follitropin for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Calcitonin for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Glucagon for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Teriparatide for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Indication for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biosimilars Market Revenues & Volume By In-house for the Period 2020 - 2030
  • United States (US) Biosimilars Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Manufacturing
  • United States (US) Biosimilars Top Companies Market Share
  • United States (US) Biosimilars Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Biosimilars Company Profiles
  • United States (US) Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):

Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Biosimilars Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Biosimilars Market Revenues & Volume, 2020 & 2030F

3.3 United States (US) Biosimilars Market - Industry Life Cycle

3.4 United States (US) Biosimilars Market - Porter's Five Forces

3.5 United States (US) Biosimilars Market Revenues & Volume Share, By Form, 2020 & 2030F

3.6 United States (US) Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2030F

3.7 United States (US) Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2030F

4 United States (US) Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Biosimilars Market Trends

6 United States (US) Biosimilars Market, By Types

6.1 United States (US) Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 United States (US) Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 United States (US) Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 United States (US) Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 United States (US) Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 United States (US) Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 United States (US) Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 United States (US) Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 United States (US) Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 United States (US) Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 United States (US) Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 United States (US) Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 United States (US) Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 United States (US) Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 United States (US) Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 United States (US) Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 United States (US) Biosimilars Market Import-Export Trade Statistics

7.1 United States (US) Biosimilars Market Export to Major Countries

7.2 United States (US) Biosimilars Market Imports from Major Countries

8 United States (US) Biosimilars Market Key Performance Indicators

9 United States (US) Biosimilars Market - Opportunity Assessment

9.1 United States (US) Biosimilars Market Opportunity Assessment, By Product, 2020 & 2030F

9.2 United States (US) Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2030F

9.3 United States (US) Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2030F

10 United States (US) Biosimilars Market - Competitive Landscape

10.1 United States (US) Biosimilars Market Revenue Share, By Companies, 2020

10.2 United States (US) Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Related Reports

Industry Events and Analyst Meet

EV INDIA EXPO 2023

EV INDIA EXPO 2023

3rd Cyber Security for Energy and Utility

3rd Cyber Security for Energy and Utility

The Big 5 Saudi

The Big 5 Saudi

Media Expo-Mumbai Digital Signage

Media Expo-Mumbai Digital Signage

Meta Cinema Forum- Ghana

Meta Cinema Forum- Ghana

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography. Read more

Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
©2024 6Wresearch, All Right Reserved